These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 3963731)
1. Serum calcitonin in thyroid disorders and in pheochromocytoma kindred. Hornicek FJ; Danowski TS; Robinson SM; Sweeney KT; Malinin GI Ann Clin Lab Sci; 1986; 16(2):103-7. PubMed ID: 3963731 [TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [TBL] [Abstract][Full Text] [Related]
3. Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery. Lips CJ; Leo JR; Berends MJ; Minder WH; Blok AP; Geerdink RA; Hackeng WH; Roelofs JM; Vasen HF; Vette JK Henry Ford Hosp Med J; 1987; 35(2-3):133-8. PubMed ID: 2891645 [No Abstract] [Full Text] [Related]
4. Results of a screening program for multiple endocrine neoplasia type II. Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of a family with the MEN-2A syndrome. Haak HR; Nieuwenhuijzen Kruseman AC Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639 [No Abstract] [Full Text] [Related]
6. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A]. Pati M; Sperti P; Magiar AV; Bonifacio V Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514 [TBL] [Abstract][Full Text] [Related]
7. [Usefulness of calcitonin measurement for the diagnosis of medullary cancer of the thyroid in a family with multiple endocrine adenoma syndrome of type IIB]. Pumarino H; Riesco J; Michelsen H; Campino C; Cembal J; Generini G Rev Med Chil; 1984 Jul; 112(7):675-80. PubMed ID: 6151224 [No Abstract] [Full Text] [Related]
8. Multiple endocrine neoplasia, type II: a combined surgical and genetic approach to treatment. Partington MW; Ghent WR; Sears EV; Simpson NE Can Med Assoc J; 1981 Feb; 124(4):403-10. PubMed ID: 7214269 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature. Oishi S; Sasaki M; Sato T; Isogai M Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591 [TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type IIb: a description of several patients and review of the literature. Montgomery TB; Mandelstam P; Tachman ML; Miller RE; Powell DE; Flueck JA; Kotchen TA J Clin Hypertens; 1987 Mar; 3(1):31-49. PubMed ID: 2883264 [TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid cancer in a Wisconsin kindred with Sipple's syndrome: the use of provoked calcitonin testing. Witte RS; Starling JR; Warner T; Davis TE Wis Med J; 1982 Nov; 81(11):22-5. PubMed ID: 6130656 [No Abstract] [Full Text] [Related]
12. Plasma norepinephrine response to standing in patients with pheochromocytoma or medullary carcinoma of the thyroid. Feldman JM; Blalock JA; Farrell RE; Wells SA Arch Intern Med; 1979 Jan; 139(1):81-5. PubMed ID: 760688 [TBL] [Abstract][Full Text] [Related]
13. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors. Saito H; Saito S Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976). Sizemore GW; Carney JA; Heath H Surg Clin North Am; 1977 Aug; 57(4):633-45. PubMed ID: 897960 [No Abstract] [Full Text] [Related]
15. [Sipple's syndrome: a study through three generations. HLA--carcino-embryonic antigen system. Preliminary results (author's transl)]. Tcherdakoff P; Colliard M; Juillet Y; Souquiere JP; Rigault C; Bacourt F; Gallet JP Ann Med Interne (Paris); 1980; 131(5):291-6. PubMed ID: 7447229 [TBL] [Abstract][Full Text] [Related]
17. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469 [TBL] [Abstract][Full Text] [Related]
18. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene. Recasens M; Oriola J; Fernández-Real JM; Roig J; Rodríguez-Hermosa JI; Font JA; Galofre P; López-Bermejo A; Ricart W Clin Endocrinol (Oxf); 2007 Jul; 67(1):29-33. PubMed ID: 17466010 [TBL] [Abstract][Full Text] [Related]
19. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. Guignat L; Bidart JM; Nocera M; Comoy E; Schlumberger M; Baudin E Br J Cancer; 2001 Mar; 84(6):808-12. PubMed ID: 11259096 [TBL] [Abstract][Full Text] [Related]
20. Detection of medullary thyroid cancer by calcitonin assay in families. Jackson CE; Tashjian AH; Block MA Ann Intern Med; 1973 Jun; 78(6):845-52. PubMed ID: 4197369 [No Abstract] [Full Text] [Related] [Next] [New Search]